Melissa Gilkey is Assistant Professor of Population Medicine at Harvard Medical School and Harvard Pilgrim Health Care Institute. With research interests in cancer prevention, adolescent health, and health services research, Dr. Gilkey studies individual and organizational approaches to improving the delivery of adolescent vaccines, including human papillomavirus (HPV) vaccine. Her work includes survey research to understand barriers to vaccination, such as parental hesitancy, as well as intervention research aimed at improving vaccine delivery systems. Dr. Gilkey is co-PI of a study funded by the Robert Wood Johnson Foundation to evaluate the CDC's AFIX (Assessment, Feedback, Incentives, and eXchange) model for improving HPV vaccine coverage in primary care settings. She also received a Transition Career Development Award (K22) from the National Cancer Institute to develop a brief communication training program aimed at supporting healthcare providers in delivering effective recommendations for HPV vaccine. Dr. Gilkey holds a PhD in the social and behavioral sciences from the Johns Hopkins Bloomberg School of Public Health.